Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

DIRECTORS' DEALING

17 Apr 2015 07:00

RNS Number : 4998K
Plant Health Care PLC
17 April 2015
 

 



Plant Health Care plc

Friday, 17 April 2015

 

PLANT HEALTH CARE plc (THE "COMPANY")

DIRECTORS' DEALING

The Company today announces that, on 16 April 2015, a total of 25,880 ordinary shares of 1p ("Ordinary Shares") were allotted to Paul Schmidt, Chief Executive Officer, in satisfaction of a half share of his (net) cash bonus for 2014. The quantum of shares allotted was based on the closing middle market price of 111.5p derived from the Daily Official List on 15 April 2015 and the exchange rate of $1: £0.68012 prevailing at that time.

Application has been made for 25,880 Ordinary Shares (the 'New Shares') to be admitted to trading on the London Stock Exchange's AIM market for listed securities ("Admission") and admission is expected to occur on 27 April 2015. The New Shares will rank pari passu with the Company's existing Ordinary Shares.

The Company today further announces that, on 16 April 2015, options over a total of 89,686 Ordinary Shares were granted to William ("Bill") M. Lewis, a non-executive director, in accordance with the terms of a share option agreement under which Bill Lewis is to be granted Ordinary Shares in the Company to the value of £100,000, exercisable (not earlier than three years from the date of his appointment) at the price per share prevailing at the date of grant (111.5p), consequent upon his appointment as a non-executive director of the Company.

Following the above-mentioned allotments of Ordinary Shares and grant of options, Paul Schmidt and Bill Lewis's beneficial interests in the enlarged Ordinary Share capital of the Company are as shown below:

 Name

Ordinary Share holding

Percentage of enlarged Ordinary Share capital

Share Options

Value Creation Plan

Paul Schmidt

82,880

0.12%

200,000

1,709,821

William Lewis

 

NIL

N/A

89,686

N/A

 

Application has been made for 7,500 Ordinary Shares to be admitted to trading on the London Stock Exchange's AIM market for listed securities. The new Ordinary Shares ("New Shares") are being issued pursuant to the acceptance of an exchange offer for minority shares formerly held in Plant Health Care, Inc. Admission is expected to become effective on 27 April 2015. The New Shares will rank pari passu with the Company's existing Ordinary Shares.

 

Following admission of these Ordinary Shares, the total issued share capital of the Company will be 71,743,085 Ordinary Shares, all of which have voting rights. There are no shares in treasury.

 

The above figure (71,743,085 Ordinary Shares) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

-: Ends :-

Enquiries:

Plant Health Care plcDr. Christopher Richards, Executive ChairmanTel: +44 (0)1837 880083ir@planthealthcare.com 

Liberum Capital - Nomad and Broker

Clayton Bush

Tel: +44 (0) 20 3100 2000

 

LHAEd McGregor / Jody BurfeningTel: +1 (212) 8383777

Company website: www.planthealthcare.com

 About Plant Health Care: Plant Health Care is a leading provider of novel patent-protected biological products to the global agriculture markets. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. The Company's ordinary shares have been quoted on the AIM market of the London Stock Exchange since July 2004 (ticker symbol: PHC).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDQLFFEZFLBBQ
Date   Source Headline
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award
19th Nov 20187:00 amRNSPlant Health Care to present at Mello London
14th Nov 20187:00 amRNSPositive Developments with Harpin
8th Nov 20187:00 amRNSChange of Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSInterim Report ended 30 June 2018
12th Sep 20187:00 amRNSUS Announces Harpin aß Product Launch in Corn
20th Aug 20187:00 amRNSBlock listing Interim Review
30th Jul 20187:00 amRNSUpdate on sugarcane in Brazil
16th Jul 20187:00 amRNSTrading Statement
6th Jun 20182:39 pmRNSHolding(s) in Company
6th Jun 201811:14 amRNSResult of AGM
30th May 20187:00 amRNSGrant of Options
4th May 20185:59 pmRNSHolding(s) in Company
30th Apr 20183:11 pmRNSPublication of Annual Report and Notice of AGM
10th Apr 20187:00 amRNSResults for the year ended 31 December 2017
8th Mar 20187:00 amRNSBlock listing Interim Review
7th Mar 20183:07 pmRNSHolding(s) in Company
7th Mar 20183:06 pmRNSHolding(s) in Company
7th Mar 20183:02 pmRNSHolding(s) in Company
2nd Mar 20185:48 pmRNSHolding(s) in Company
27th Feb 20184:12 pmRNSResult of Placing and Subscription
27th Feb 20187:00 amRNSProposed Placing and Subscription
24th Jan 20187:00 amRNSTrading Statement
12th Dec 20177:00 amRNSNew Technology Update
8th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20174:40 pmRNSSecond Price Monitoring Extn
6th Dec 20174:35 pmRNSPrice Monitoring Extension
18th Sep 20177:00 amRNSHalf-year Report
21st Aug 20177:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.